688336.SH
三生国健
SSE · Healthcare · Biotechnology · CN
CNY 43.45
−8.81%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 4.3B | 4.2B | 1.2B | 1.0B | 825.5M |
| Cost of Revenue | 341.1M | 333.0M | 304.3M | 224.1M | 201.2M |
| Gross Profit | 4.0B | 3.9B | 889.2M | 789.9M | 624.3M |
| Operating Expenses | |||||
| R&D Expense | 447.2M | 435.0M | 356.5M | 282.3M | 313.3M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 111.4M | 101.0M | 79.2M | 63.1M | 82.7M |
| Selling & Marketing Expense | 196.7M | 198.7M | 237.5M | 251.8M | 250.4M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 756.9M | 703.7M | 631.3M | 567.6M | 630.7M |
| Cost and Expenses | 1.1B | 1.0B | 935.7M | 791.7M | 831.9M |
| Operating Income (EBIT) | 3.4B | 3.3B | 726.5M | 318.2M | 36.9M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 3.4B | 3.3B | 707.7M | 310.6M | 29.0M |
| Income Tax Expense | 434.4M | 426.7M | 16.3M | 27.3M | (16.5M) |
| Bottom Line | |||||
| Net Income | 3.0B | 2.9B | 704.6M | 294.6M | 49.3M |
| Earnings from Cont. Ops | 3.0B | 2.9B | 691.4M | 283.4M | 45.4M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 3.0B | 2.9B | 704.6M | 294.6M | 49.3M |
| Per Share | |||||
| Basic EPS | CN¥4.83 | CN¥4.70 | CN¥1.14 | CN¥0.48 | CN¥0.08 |
| Diluted EPS | CN¥4.83 | CN¥4.68 | CN¥1.14 | CN¥0.48 | CN¥0.08 |
| Revenue Per Share | CN¥7.03 | CN¥6.81 | CN¥1.93 | CN¥1.65 | CN¥1.34 |
| Shares | |||||
| Basic Shares Outstanding | 614.2M | 616.9M | 618.1M | 613.8M | 616.2M |
| Diluted Shares Outstanding | 614.2M | 616.9M | 618.1M | 613.8M | 616.2M |
| Profitability Metrics | |||||
| EBITDA | — | 3.5B | 854.5M | 414.3M | 159.4M |
| D&A | — | 123.8M | 128.0M | 96.1M | 122.4M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026